肝移植受者对新冠病毒疫苗的高接种率 - Suppr

High acceptance rate of COVID-19 vaccination in liver transplant recipients.

作者信息

Giannini Edoardo G, Marenco Simona

机构信息

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

出版信息

J Hepatol. 2021 Aug;75(2):483-484. doi: 10.1016/j.jhep.2021.05.009. Epub 2021 May 28.

DOI:10.1016/j.jhep.2021.05.009

PMID:34052253

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159704/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/addf/8159704/0e989ace51fa/gr1_lrg.jpg

相似文献

High acceptance rate of COVID-19 vaccination in liver transplant recipients.肝移植受者对新冠病毒疫苗的高接种率

J Hepatol. 2021 Aug;75(2):483-484. doi: 10.1016/j.jhep.2021.05.009. Epub 2021 May 28.

Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.肝移植受者和候选者对 SARS-CoV-2 疫苗的接受情况。

Z Gastroenterol. 2021 Dec;59(12):1288-1296. doi: 10.1055/a-1649-8568. Epub 2021 Oct 20.

Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.一名肝移植受者接种基于mRNA的SARS-CoV-2疫苗后的肝损伤

Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.

Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.肝移植受者的新冠病毒疫苗接种：在不利环境中的“圣杯”。

Liver Int. 2022 Jun;42(6):1225-1228. doi: 10.1111/liv.15226.

SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for.肝移植受者接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗：我们仍未找到我们所寻找的答案。

Ann Hepatol. 2023 May-Jun;28(3):101081. doi: 10.1016/j.aohep.2023.101081. Epub 2023 Mar 5.

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.抗SARS-CoV-2 mRNA疫苗对肝移植等待名单上的患者及肝移植受者疗效的临床最新情况

Dig Liver Dis. 2021 Oct;53(10):1232-1234. doi: 10.1016/j.dld.2021.07.019. Epub 2021 Jul 29.

Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.《沙特肝病研究与移植协会关于肝病和肝移植患者使用 COVID-19 疫苗的立场声明》

Saudi J Gastroenterol. 2021 Jul-Aug;27(4):201-207. doi: 10.4103/sjg.sjg_223_21.

Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。

Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.

Impact of Shielding and First Dose of COVID-19 Vaccination in Kidney Transplant Recipients.屏蔽防护和首剂新冠疫苗接种对肾移植受者的影响

Nephron. 2022;146(1):64-66. doi: 10.1159/000518631. Epub 2021 Sep 2.

Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.肾移植受者首次接种mRNA新冠疫苗后抗SARS-CoV-2抗体反应较弱。

Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26.

引用本文的文献

The impact of COVID-19 on liver transplantation: challenges and perspectives.2019年冠状病毒病对肝移植的影响：挑战与展望

Therap Adv Gastroenterol. 2023 May 10;16:17562848231171452. doi: 10.1177/17562848231171452. eCollection 2023.

New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.新型冠状病毒肺炎疫苗接种后新发和复发肝病：系统评价。

BMC Gastroenterol. 2022 Oct 13;22(1):433. doi: 10.1186/s12876-022-02507-3.

Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种或新型冠状病毒肺炎（COVID-19）感染后的实体器官排斥反应：一项系统评价和荟萃分析

Vaccines (Basel). 2022 Aug 10;10(8):1289. doi: 10.3390/vaccines10081289.

Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.霉酚酸酯降低肝移植受者对三剂 SARS-CoV-2 疫苗的体液反应。

Liver Int. 2022 Aug;42(8):1872-1878. doi: 10.1111/liv.15258. Epub 2022 Apr 2.

COVID-19 Vaccine Acceptance among Liver Transplant Recipients.肝移植受者对新冠病毒疫苗的接受情况

Vaccines (Basel). 2021 Nov 11;9(11):1314. doi: 10.3390/vaccines9111314.

Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients.是否受到保护，这就是问题所在——关于非酒精性脂肪性肝病患者和肝移植受者对新冠病毒疫苗反应的首批数据。

J Hepatol. 2021 Aug;75(2):265-266. doi: 10.1016/j.jhep.2021.05.007. Epub 2021 May 25.

本文引用的文献

Italian association for the study of the liver position statement on SARS-CoV2 vaccination.意大利肝脏研究协会关于 SARS-CoV2 疫苗接种的立场声明。

Dig Liver Dis. 2021 Jun;53(6):677-681. doi: 10.1016/j.dld.2021.03.013. Epub 2021 Apr 30.

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.肝移植受者对 SARS-CoV-2 疫苗的免疫原性较低。

J Hepatol. 2021 Aug;75(2):435-438. doi: 10.1016/j.jhep.2021.04.020. Epub 2021 Apr 21.

[Not Available].[无可用内容]

Z Gastroenterol. 2021 Apr;59(4):345-359. doi: 10.1055/a-1372-5595. Epub 2021 Apr 12.

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.EASL 立场文件：关于在慢性肝病、肝胆癌和肝移植受者中使用 COVID-19 疫苗的建议。

J Hepatol. 2021 Apr;74(4):944-951. doi: 10.1016/j.jhep.2021.01.032. Epub 2021 Feb 6.

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.年龄和合并症是肝移植受者因 COVID-19 死亡风险的核心因素。

J Hepatol. 2021 Jul;75(1):226-228. doi: 10.1016/j.jhep.2021.01.036. Epub 2021 Feb 5.

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。

N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。

Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。

N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.

A global survey of potential acceptance of a COVID-19 vaccine.一项针对 COVID-19 疫苗潜在接受度的全球调查。

Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.

Determining risk factors for mortality in liver transplant patients with COVID-19.确定感染新型冠状病毒肺炎的肝移植患者的死亡风险因素。

Lancet Gastroenterol Hepatol. 2020 Jul;5(7):643-644. doi: 10.1016/S2468-1253(20)30125-4. Epub 2020 Apr 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

High acceptance rate of COVID-19 vaccination in liver transplant recipients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献